Kevin Nowakowski
Internal Medicine Residency · Indiana University School of Medicine
Credentials: ·
History
- 2021–2025
Doctor of Medicine
Research
Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma
Blood · 2019 · 50 citations
Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester disease
Case report · American Journal of Hematology · 2022 · 24 citations
iScience · 2023 · 16 citations
7 papers
7 papers
4 papers
3 papers · 3 as a fellow
- GR
3 papers · 3 as a resident
- RK
3 papers
3 papers
2 papers
